Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial-Reference-Cited by-同舟云学术

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

Published:2020-07 Issue:7 Volume:19 Page:582-590
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Cukierman-Yaffe Tali,Gerstein Hertzel C,Colhoun Helen M,Diaz Rafael,García-Pérez Luis-Emilio,Lakshmanan Mark,Bethel Angelyn,Xavier Denis,Probstfield Jeffrey,Riddle Matthew C,Rydén Lars,Atisso Charles Messan,Hall Stephanie,Rao-Melacini Purnima,Basile Jan,Cushman William C,Franek Edward,Keltai Matyas,Lanas Fernando,Leiter Lawrence A,Lopez-Jaramillo Patricio,Pirags Valdis,Pogosova Nana,Raubenheimer Peter J,Shaw Jonathan E,Sheu Wayne H-H,Temelkova-Kurktschiev Theodora

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference30 articles.

1. Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies;Gudala;J Diabetes Investig,2013

2. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies;Cukierman;Diabetologia,2005

3. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy;Feil;J Am Geriatr Soc,2011

4. Vascular cognitive impairment;O'Brien;Lancet Neurol,2003

5. Cognitive impairment and cardiovascular disease: a comparison of risk factors, disability, quality of life, and access to health care;Adams;Public Health Rep,2020

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DPP-4 inhibition by linagliptin ameliorates age-related mild cognitive impairment by regulating microglia polarization in mice;Experimental Neurology;2024-03

2. Pharmacological interventions in human aging;Ageing Research Reviews;2024-02

3. Alterations of spontaneous brain activity in type 2 diabetes mellitus without mild cognitive impairment: a resting-state functional magnetic resonance study;Frontiers in Human Neuroscience;2024-01-11

4. Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial;Diabetes, Obesity and Metabolism;2024-01-10

5. Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer’s Disease;Biomedicines;2024-01-03